Bridging waiting time with internet-based self-help for bulimia nervosa, binge eating disorders and other specified feeding and eating disorders

Using Internet-based self-help to bridge waiting time for face-to-face outpatient treatment for Bulimia Nervosa, Binge Eating Disorder and Other Specified Feeding and Eating Disorders (OSFED)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12608780

Enrollment

275

Registered

2016-02-26

Start date

2016-11-16

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bulimia nervosa, binge eating disorder or other specified feeding or eating disorder (OSFED) Mental and Behavioural Disorders 1. Bulimia Nervosa 2. Binge Eating Disorder 3. Other specified feeding or eating disorder (OSFED)

Interventions

Participants are randomly allocated to one of two groups. Intervention group: Participants will receive everyBody Plus, based on eating disorder-specific cognitive-behavioural therapy. It consists of

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women aged 18 or older 2. Seeking treatment from cooperating psychotherapists for Bulimia nervosa, Binge Eating Disorder or OSFED 3. Access to the Internet 4. Informed consent (online)

Exclusion criteria

Exclusion criteria: 1. Women not eligible for treatment due to low symptom severity, according to judgement of cooperating therapist 2. Women with a BMI under 18.5 3. Women with an indication for inpatient eating disorder treatment according to judgement of cooperating therapist 4. Women with significant psychiatric comorbidity needing treatment in its own right (e.g., substance dependence), major psychiatric disorders (e.g., psychosis) or are acutely suicidal women 5. Women receiving antidepressant medication who have not been on a stable dose for at least four weeks

Design outcomes

Primary

Measure	Time frame
Number of weeks after randomisation until a patient achieves a clinical relevant improvement* in core symptoms for the first time will be measured using a weekly symptom monitoring that includes questions about the number of binge eating and compensatory behaviours (vomiting, fasting, excessive exercise, use of laxatives, diuretics or appetite suppressants) and the current body weight of the participant. *Clinically relevant improvement is defined as abstinence from binge eating and compensatory behaviours (vomiting, fasting, excessive exercise, use of laxatives, diuretics or appetite suppressants) and a BMI of over 18.5, over a period of at least four weeks. Weekly symptom monitoring continues until 12 months post randomisation.	—

Measure

Time frame

Number of weeks after randomisation until a patient achieves a clinical relevant improvement* in core symptoms for the first time will be measured using a weekly symptom monitoring that includes questions about the number of binge eating and compensatory behaviours (vomiting, fasting, excessive exercise, use of laxatives, diuretics or appetite suppressants) and the current body weight of the participant. *Clinically relevant improvement is defined as abstinence from binge eating and compensatory behaviours (vomiting, fasting, excessive exercise, use of laxatives, diuretics or appetite suppressants) and a BMI of over 18.5, over a period of at least four weeks. Weekly symptom monitoring continues until 12 months post randomisation.

—

Secondary

Measure	Time frame
1. Number of therapy sessions after randomisation until a participant achieves a clinical relevant improvement for the first time. To obtain this information, cooperating therapists will be asked to provide information about the number of therapy session utilized by the participant once per quarter. 2. Frequencies of core eating disorder symptoms (i.e., binge eating, compensatory behaviours) in the previous month will be measured by self-report at baseline, post-intervention, 6 and 12 months follow up 3. Eating disorder psychopathology will be measured using the Eating Disorder Examination Questionnaire (EDE-Q) at baseline, post intervention, 6 and 12 months follow up 4. Body image concerns will be measured using the Weight Concerns Scale (WCS) at baseline, post intervention, 6 and 12 months follow up 5. Intuitive Eating will be measured using the Intuitive Eating Scale (IES) at baseline, post intervention, 6 and 12 months follow up 6. Fruit- and vegetable consumption will be measures by self-report at baseline, post-intervention, 6 and 12 months follow up 7. Depression will be measured using the PHQ-9 at baseline, post intervention, 6 and 12 months follow up 8. Anxiety will be measured using the GAD-7 at baseline, post intervention, 6 and 12 months follow up 9. Alcohol consumption will be measures using the The Alcohol Use Disorders Identification Test (AUDIT-C) at baseline, post intervention, 6 and 12 months follow up 10. Quality of life will be measured by the Assessment of Quality of Life-8D (AQoL-8D) questionnaire at baseline, post intervention, 6 and 12 months follow up 11. Self-Esteem will be measured using the Rosenberg Self-Esteem Scale (RSE) at baseline, post intervention, 6 and 12 months follow up 12. Self-regulation skills will be measures using the Short Self-Regulation Questionnaire (SSRQ) at baseline, post intervention, 6 and 12 months follow up The following additional outcomes will be measured at start of trial, half-way through and at end of the	—

Measure

Time frame

1. Number of therapy sessions after randomisation until a participant achieves a clinical relevant improvement for the first time. To obtain this information, cooperating therapists will be asked to provide information about the number of therapy session utilized by the participant once per quarter. 2. Frequencies of core eating disorder symptoms (i.e., binge eating, compensatory behaviours) in the previous month will be measured by self-report at baseline, post-intervention, 6 and 12 months follow up 3. Eating disorder psychopathology will be measured using the Eating Disorder Examination Questionnaire (EDE-Q) at baseline, post intervention, 6 and 12 months follow up 4. Body image concerns will be measured using the Weight Concerns Scale (WCS) at baseline, post intervention, 6 and 12 months follow up 5. Intuitive Eating will be measured using the Intuitive Eating Scale (IES) at baseline, post intervention, 6 and 12 months follow up 6. Fruit- and vegetable consumption will be measures by self-report at baseline, post-intervention, 6 and 12 months follow up 7. Depression will be measured using the PHQ-9 at baseline, post intervention, 6 and 12 months follow up 8. Anxiety will be measured using the GAD-7 at baseline, post intervention, 6 and 12 months follow up 9. Alcohol consumption will be measures using the The Alcohol Use Disorders Identification Test (AUDIT-C) at baseline, post intervention, 6 and 12 months follow up 10. Quality of life will be measured by the Assessment of Quality of Life-8D (AQoL-8D) questionnaire at baseline, post intervention, 6 and 12 months follow up 11. Self-Esteem will be measured using the Rosenberg Self-Esteem Scale (RSE) at baseline, post intervention, 6 and 12 months follow up 12. Self-regulation skills will be measures using the Short Self-Regulation Questionnaire (SSRQ) at baseline, post intervention, 6 and 12 months follow up The following additional outcomes will be measured at start of trial, half-way through and at end of the

—

Countries

England, Germany, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026